HEADER OXIDOREDUCTASE 21-OCT-11 3UAS TITLE CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED TITLE 2 INACTIVATOR 9-ETHYNYLPHENANTHRENE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 2B4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYPIIB4, CYTOCHROME P450 ISOZYME 2, CYTOCHROME P450 LM2, COMPND 5 CYTOCHROME P450 TYPE B0, CYTOCHROME P450 TYPE B1; COMPND 6 EC: 1.14.14.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: EUROPEAN RABBIT,JAPANESE WHITE RABBIT,DOMESTIC SOURCE 4 RABBIT,RABBITS; SOURCE 5 ORGANISM_TAXID: 9986; SOURCE 6 GENE: CYP2B4; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: TOPP3; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PKK KEYWDS P450, CYTOCHROME P450 2B4, MONOOXYGENASE, OXIDOREDUCTASE, MEMBRANE KEYWDS 2 PROTEIN, CYP 2B4, CYP LM2 EXPDTA X-RAY DIFFRACTION AUTHOR S.C.GAY,H.ZHANG,M.B.SHAH,C.D.STOUT,J.R.HALPERT,P.F.HOLLENBERG REVDAT 4 13-SEP-23 3UAS 1 REMARK SEQADV LINK REVDAT 3 24-JAN-18 3UAS 1 AUTHOR REVDAT 2 30-JAN-13 3UAS 1 JRNL REVDAT 1 09-JAN-13 3UAS 0 JRNL AUTH H.ZHANG,S.C.GAY,M.SHAH,M.FOROOZESH,J.LIU,Y.OSAWA,Q.ZHANG, JRNL AUTH 2 C.D.STOUT,J.R.HALPERT,P.F.HOLLENBERG JRNL TITL POTENT MECHANISM-BASED INACTIVATION OF CYTOCHROME P450 2B4 JRNL TITL 2 BY 9-ETHYNYLPHENANTHRENE: IMPLICATIONS FOR ALLOSTERIC JRNL TITL 3 MODULATION OF CYTOCHROME P450 CATALYSIS. JRNL REF BIOCHEMISTRY V. 52 355 2013 JRNL REFN ISSN 0006-2960 JRNL PMID 23276288 JRNL DOI 10.1021/BI301567Z REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.ZHAO,M.A.WHITE,B.K.MURALIDHARA,L.SUN,J.R.HALPERT,C.D.STOUT REMARK 1 TITL STRUCTURE OF MICROSOMAL CYTOCHROME P450 2B4 COMPLEXED WITH REMARK 1 TITL 2 THE ANTIFUNGAL DRUG BIFONAZOLE: INSIGHT INTO P450 REMARK 1 TITL 3 CONFORMATIONAL PLASTICITY AND MEMBRANE INTERACTION. REMARK 1 REF J.BIOL.CHEM. V. 281 5973 2006 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 16373351 REMARK 1 DOI 10.1074/JBC.M511464200 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.E.SCOTT,M.A.WHITE,Y.A.HE,E.F.JOHNSON,C.D.STOUT,J.R.HALPERT REMARK 1 TITL STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 COMPLEXED WITH REMARK 1 TITL 2 4-(4-CHLOROPHENYL)IMIDAZOLE AT 1.9-A RESOLUTION: INSIGHT REMARK 1 TITL 3 INTO THE RANGE OF P450 CONFORMATIONS AND THE COORDINATION OF REMARK 1 TITL 4 REDOX PARTNER BINDING. REMARK 1 REF J.BIOL.CHEM. V. 279 27294 2004 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 15100217 REMARK 1 DOI 10.1074/JBC.M403349200 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.E.SCOTT,Y.A.HE,M.R.WESTER,M.A.WHITE,C.C.CHIN,J.R.HALPERT, REMARK 1 AUTH 2 E.F.JOHNSON,C.D.STOUT REMARK 1 TITL AN OPEN CONFORMATION OF MAMMALIAN CYTOCHROME P450 2B4 AT REMARK 1 TITL 2 1.6-A RESOLUTION. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 100 13196 2003 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 14563924 REMARK 1 DOI 10.1073/PNAS.2133986100 REMARK 1 REFERENCE 4 REMARK 1 AUTH Y.ZHAO,L.SUN,B.K.MURALIDHARA,S.KUMAR,M.A.WHITE,C.D.STOUT, REMARK 1 AUTH 2 J.R.HALPERT REMARK 1 TITL STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF REMARK 1 TITL 2 1-(4-CHLOROPHENYL)IMIDAZOLE BINDING TO CYTOCHROME P450 2B4. REMARK 1 REF BIOCHEMISTRY V. 46 11559 2007 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 17887776 REMARK 1 DOI 10.1021/BI7011614 REMARK 1 REFERENCE 5 REMARK 1 AUTH S.C.GAY,L.SUN,K.MAEKAWA,J.R.HALPERT,C.D.STOUT REMARK 1 TITL CRYSTAL STRUCTURES OF CYTOCHROME P450 2B4 IN COMPLEX WITH REMARK 1 TITL 2 THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE: REMARK 1 TITL 3 LIGAND-INDUCED STRUCTURAL RESPONSE THROUGH ALPHA-HELICAL REMARK 1 TITL 4 REPOSITIONING. REMARK 1 REF BIOCHEMISTRY V. 48 4762 2009 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 19397311 REMARK 1 DOI 10.1021/BI9003765 REMARK 1 REFERENCE 6 REMARK 1 AUTH S.C.GAY,A.G.ROBERTS,K.MAEKAWA,J.C.TALAKAD,W.X.HONG,Q.ZHANG, REMARK 1 AUTH 2 C.D.STOUT,J.R.HALPERT REMARK 1 TITL STRUCTURES OF CYTOCHROME P450 2B4 COMPLEXED WITH THE REMARK 1 TITL 2 ANTIPLATELET DRUGS TICLOPIDINE AND CLOPIDOGREL . REMARK 1 REF BIOCHEMISTRY V. 49 8709 2010 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 20815363 REMARK 1 DOI 10.1021/BI100914Z REMARK 1 REFERENCE 7 REMARK 1 AUTH P.R.WILDERMAN,M.B.SHAH,T.LIU,S.LI,S.HSU,A.G.ROBERTS, REMARK 1 AUTH 2 D.R.GOODLETT,Q.ZHANG,V.L.WOODS,C.D.STOUT,J.R.HALPERT REMARK 1 TITL PLASTICITY OF CYTOCHROME P450 2B4 AS INVESTIGATED BY REMARK 1 TITL 2 HYDROGEN-DEUTERIUM EXCHANGE MASS SPECTROMETRY AND X-RAY REMARK 1 TITL 3 CRYSTALLOGRAPHY. REMARK 1 REF J.BIOL.CHEM. V. 285 38602 2010 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 20880847 REMARK 1 DOI 10.1074/JBC.M110.180646 REMARK 1 REFERENCE 8 REMARK 1 AUTH S.C GAY,H.ZHANG,P.R.WILDERMAN,A.G.ROBERTS,T.LIU,S.LI, REMARK 1 AUTH 2 H.L.LIN,V.L.WOODS JR.,C.D.STOUT,P.F.HOLLENBERG,J.R.HALPERT REMARK 1 TITL STRUCTURAL ANALYSIS OF MAMMALIAN CYTOCHROME P450 2B4 REMARK 1 TITL 2 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR REMARK 1 TITL 3 TERT-BUTYLPHENYLACETYLENE: INSIGHT INTO PARTIAL ENZYMATIC REMARK 1 TITL 4 ACTIVITY REMARK 1 REF BIOCHEMISTRY V. 50 4903 2011 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 21510666 REMARK 1 DOI 10.1021/BI200482G REMARK 2 REMARK 2 RESOLUTION. 2.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 15379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.296 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 765 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.02 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1045 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3696 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.90000 REMARK 3 B22 (A**2) : -0.90000 REMARK 3 B33 (A**2) : 1.35000 REMARK 3 B12 (A**2) : -0.45000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.458 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.363 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.568 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.866 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.804 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3905 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5300 ; 0.952 ; 2.023 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 457 ; 4.774 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 178 ;34.467 ;22.640 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 637 ;14.550 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;14.664 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 578 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2972 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2307 ; 0.269 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3745 ; 0.501 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1598 ; 0.486 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1555 ; 0.893 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 3UAS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1000068520. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OTHER REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : QUAZAR MX MICROFOCUS SOURCE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : APEX II CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XPREP 2008/2 FOR WINDOWS, SAINT REMARK 200 DATA SCALING SOFTWARE : SAINT REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15444 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.939 REMARK 200 RESOLUTION RANGE LOW (A) : 78.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.12800 REMARK 200 R SYM (I) : 0.12800 REMARK 200 FOR THE DATA SET : 12.7300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.61 REMARK 200 R MERGE FOR SHELL (I) : 0.39500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.1.4 REMARK 200 STARTING MODEL: PDB ENTRY 1SUO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 20% (W/V) PEG 3000, 0.2 M REMARK 280 CALCIUM ACETATE, PH 7.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.54100 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 99.08200 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 99.08200 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 49.54100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER. THERE IS ONE BIOLOGICAL REMARK 300 UNIT IN THE ASYMMETRIC UNIT (CHAIN A). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 LYS A 22 REMARK 465 LYS A 23 REMARK 465 THR A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 LYS A 27 REMARK 465 PHE A 135 REMARK 465 GLY A 136 REMARK 465 MET A 137 REMARK 465 GLY A 138 REMARK 465 HIS A 493 REMARK 465 HIS A 494 REMARK 465 HIS A 495 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 49 CG CD CE NZ REMARK 470 GLU A 60 CD OE1 OE2 REMARK 470 ARG A 422 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 29 91.91 56.79 REMARK 500 PRO A 31 152.06 -49.57 REMARK 500 SER A 430 -162.71 60.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 436 SG REMARK 620 2 HEM A 500 NA 96.2 REMARK 620 3 HEM A 500 NB 88.6 90.5 REMARK 620 4 HEM A 500 NC 85.1 178.6 88.9 REMARK 620 5 HEM A 500 ND 92.1 91.9 177.4 88.6 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0BV A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TAM A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CM5 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TAM A 504 REMARK 999 REMARK 999 SEQUENCE REMARK 999 P221S MUTATION IS DUE TO AN ERROR IN THE O00178 SEQUENCE DBREF 3UAS A 1 491 UNP P00178 CP2B4_RABIT 1 491 SEQADV 3UAS ALA A 2 UNP P00178 GLU 2 ENGINEERED MUTATION SEQADV 3UAS A UNP P00178 PHE 3 DELETION SEQADV 3UAS A UNP P00178 SER 4 DELETION SEQADV 3UAS A UNP P00178 LEU 5 DELETION SEQADV 3UAS A UNP P00178 LEU 6 DELETION SEQADV 3UAS A UNP P00178 LEU 7 DELETION SEQADV 3UAS A UNP P00178 LEU 8 DELETION SEQADV 3UAS A UNP P00178 LEU 9 DELETION SEQADV 3UAS A UNP P00178 ALA 10 DELETION SEQADV 3UAS A UNP P00178 PHE 11 DELETION SEQADV 3UAS A UNP P00178 LEU 12 DELETION SEQADV 3UAS A UNP P00178 ALA 13 DELETION SEQADV 3UAS A UNP P00178 GLY 14 DELETION SEQADV 3UAS A UNP P00178 LEU 15 DELETION SEQADV 3UAS A UNP P00178 LEU 16 DELETION SEQADV 3UAS A UNP P00178 LEU 17 DELETION SEQADV 3UAS A UNP P00178 LEU 18 DELETION SEQADV 3UAS A UNP P00178 LEU 19 DELETION SEQADV 3UAS A UNP P00178 PHE 20 DELETION SEQADV 3UAS A UNP P00178 ARG 21 DELETION SEQADV 3UAS LYS A 22 UNP P00178 GLY 22 ENGINEERED MUTATION SEQADV 3UAS LYS A 23 UNP P00178 HIS 23 ENGINEERED MUTATION SEQADV 3UAS THR A 24 UNP P00178 PRO 24 ENGINEERED MUTATION SEQADV 3UAS SER A 25 UNP P00178 LYS 25 ENGINEERED MUTATION SEQADV 3UAS SER A 26 UNP P00178 ALA 26 ENGINEERED MUTATION SEQADV 3UAS LYS A 27 UNP P00178 HIS 27 ENGINEERED MUTATION SEQADV 3UAS LYS A 29 UNP P00178 ARG 29 ENGINEERED MUTATION SEQADV 3UAS SER A 221 UNP P00178 PRO 221 SEE REMARK 999 SEQADV 3UAS TYR A 226 UNP P00178 HIS 226 ENGINEERED MUTATION SEQADV 3UAS HIS A 492 UNP P00178 EXPRESSION TAG SEQADV 3UAS HIS A 493 UNP P00178 EXPRESSION TAG SEQADV 3UAS HIS A 494 UNP P00178 EXPRESSION TAG SEQADV 3UAS HIS A 495 UNP P00178 EXPRESSION TAG SEQRES 1 A 476 MET ALA LYS LYS THR SER SER LYS GLY LYS LEU PRO PRO SEQRES 2 A 476 GLY PRO SER PRO LEU PRO VAL LEU GLY ASN LEU LEU GLN SEQRES 3 A 476 MET ASP ARG LYS GLY LEU LEU ARG SER PHE LEU ARG LEU SEQRES 4 A 476 ARG GLU LYS TYR GLY ASP VAL PHE THR VAL TYR LEU GLY SEQRES 5 A 476 SER ARG PRO VAL VAL VAL LEU CYS GLY THR ASP ALA ILE SEQRES 6 A 476 ARG GLU ALA LEU VAL ASP GLN ALA GLU ALA PHE SER GLY SEQRES 7 A 476 ARG GLY LYS ILE ALA VAL VAL ASP PRO ILE PHE GLN GLY SEQRES 8 A 476 TYR GLY VAL ILE PHE ALA ASN GLY GLU ARG TRP ARG ALA SEQRES 9 A 476 LEU ARG ARG PHE SER LEU ALA THR MET ARG ASP PHE GLY SEQRES 10 A 476 MET GLY LYS ARG SER VAL GLU GLU ARG ILE GLN GLU GLU SEQRES 11 A 476 ALA ARG CYS LEU VAL GLU GLU LEU ARG LYS SER LYS GLY SEQRES 12 A 476 ALA LEU LEU ASP ASN THR LEU LEU PHE HIS SER ILE THR SEQRES 13 A 476 SER ASN ILE ILE CYS SER ILE VAL PHE GLY LYS ARG PHE SEQRES 14 A 476 ASP TYR LYS ASP PRO VAL PHE LEU ARG LEU LEU ASP LEU SEQRES 15 A 476 PHE PHE GLN SER PHE SER LEU ILE SER SER PHE SER SER SEQRES 16 A 476 GLN VAL PHE GLU LEU PHE SER GLY PHE LEU LYS TYR PHE SEQRES 17 A 476 PRO GLY THR HIS ARG GLN ILE TYR ARG ASN LEU GLN GLU SEQRES 18 A 476 ILE ASN THR PHE ILE GLY GLN SER VAL GLU LYS HIS ARG SEQRES 19 A 476 ALA THR LEU ASP PRO SER ASN PRO ARG ASP PHE ILE ASP SEQRES 20 A 476 VAL TYR LEU LEU ARG MET GLU LYS ASP LYS SER ASP PRO SEQRES 21 A 476 SER SER GLU PHE HIS HIS GLN ASN LEU ILE LEU THR VAL SEQRES 22 A 476 LEU SER LEU PHE PHE ALA GLY THR GLU THR THR SER THR SEQRES 23 A 476 THR LEU ARG TYR GLY PHE LEU LEU MET LEU LYS TYR PRO SEQRES 24 A 476 HIS VAL THR GLU ARG VAL GLN LYS GLU ILE GLU GLN VAL SEQRES 25 A 476 ILE GLY SER HIS ARG PRO PRO ALA LEU ASP ASP ARG ALA SEQRES 26 A 476 LYS MET PRO TYR THR ASP ALA VAL ILE HIS GLU ILE GLN SEQRES 27 A 476 ARG LEU GLY ASP LEU ILE PRO PHE GLY VAL PRO HIS THR SEQRES 28 A 476 VAL THR LYS ASP THR GLN PHE ARG GLY TYR VAL ILE PRO SEQRES 29 A 476 LYS ASN THR GLU VAL PHE PRO VAL LEU SER SER ALA LEU SEQRES 30 A 476 HIS ASP PRO ARG TYR PHE GLU THR PRO ASN THR PHE ASN SEQRES 31 A 476 PRO GLY HIS PHE LEU ASP ALA ASN GLY ALA LEU LYS ARG SEQRES 32 A 476 ASN GLU GLY PHE MET PRO PHE SER LEU GLY LYS ARG ILE SEQRES 33 A 476 CYS LEU GLY GLU GLY ILE ALA ARG THR GLU LEU PHE LEU SEQRES 34 A 476 PHE PHE THR THR ILE LEU GLN ASN PHE SER ILE ALA SER SEQRES 35 A 476 PRO VAL PRO PRO GLU ASP ILE ASP LEU THR PRO ARG GLU SEQRES 36 A 476 SER GLY VAL GLY ASN VAL PRO PRO SER TYR GLN ILE ARG SEQRES 37 A 476 PHE LEU ALA ARG HIS HIS HIS HIS HET HEM A 500 43 HET 0BV A 501 17 HET TAM A 503 11 HET CM5 A 502 34 HET TAM A 504 11 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM 0BV PHENANTHREN-9-YLACETALDEHYDE HETNAM TAM TRIS(HYDROXYETHYL)AMINOMETHANE HETNAM CM5 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE HETSYN HEM HEME HETSYN 0BV 9-ETHYLPHENANTHRENE, OXIDIZED AND BOUND FORM HETSYN CM5 5-CYCLOHEXYLPENTYL 4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D- HETSYN 2 CM5 GLUCOPYRANOSIDE; CYMAL-5 FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 0BV C16 H12 O FORMUL 4 TAM 2(C7 H17 N O3) FORMUL 5 CM5 C23 H42 O11 FORMUL 7 HOH *72(H2 O) HELIX 1 1 ASN A 42 MET A 46 5 5 HELIX 2 2 GLY A 50 GLY A 63 1 14 HELIX 3 3 GLY A 80 VAL A 89 1 10 HELIX 4 4 VAL A 104 GLN A 109 1 6 HELIX 5 5 ASN A 117 ARG A 133 1 17 HELIX 6 6 SER A 141 SER A 160 1 20 HELIX 7 7 ASN A 167 PHE A 184 1 18 HELIX 8 8 ASP A 192 SER A 210 1 19 HELIX 9 9 SER A 211 LYS A 225 1 15 HELIX 10 10 GLY A 229 LEU A 256 1 28 HELIX 11 11 ASP A 263 ASP A 275 1 13 HELIX 12 12 HIS A 284 THR A 300 1 17 HELIX 13 13 THR A 300 TYR A 317 1 18 HELIX 14 14 TYR A 317 ILE A 332 1 16 HELIX 15 15 ALA A 339 LYS A 345 5 7 HELIX 16 16 MET A 346 ASP A 361 1 16 HELIX 17 17 LEU A 392 HIS A 397 1 6 HELIX 18 18 ASN A 409 LEU A 414 5 6 HELIX 19 19 LEU A 431 ILE A 435 5 5 HELIX 20 20 GLY A 438 ASN A 456 1 19 HELIX 21 21 PRO A 464 ILE A 468 5 5 SHEET 1 A 5 VAL A 65 LEU A 70 0 SHEET 2 A 5 ARG A 73 LEU A 78 -1 O VAL A 75 N VAL A 68 SHEET 3 A 5 GLU A 387 PRO A 390 1 O PHE A 389 N LEU A 78 SHEET 4 A 5 HIS A 369 THR A 370 -1 N HIS A 369 O VAL A 388 SHEET 5 A 5 GLY A 97 ARG A 98 -1 N GLY A 97 O THR A 370 SHEET 1 B 3 LEU A 165 ASP A 166 0 SHEET 2 B 3 GLN A 485 ALA A 490 -1 O ILE A 486 N LEU A 165 SHEET 3 B 3 PHE A 457 ALA A 460 -1 N ALA A 460 O ARG A 487 SHEET 1 C 2 THR A 375 PHE A 377 0 SHEET 2 C 2 TYR A 380 ILE A 382 -1 O ILE A 382 N THR A 375 SHEET 1 D 2 GLU A 474 SER A 475 0 SHEET 2 D 2 ASN A 479 VAL A 480 -1 O VAL A 480 N GLU A 474 LINK OG1 THR A 302 CAB 0BV A 501 1555 1555 1.45 LINK SG CYS A 436 FE HEM A 500 1555 1555 2.43 SITE 1 AC1 20 ARG A 98 ILE A 114 TRP A 121 ARG A 125 SITE 2 AC1 20 ILE A 179 GLY A 299 THR A 302 THR A 303 SITE 3 AC1 20 THR A 306 ILE A 363 VAL A 367 HIS A 369 SITE 4 AC1 20 PRO A 428 PHE A 429 SER A 430 ARG A 434 SITE 5 AC1 20 CYS A 436 LEU A 437 GLY A 438 ALA A 442 SITE 1 AC2 5 ILE A 114 ALA A 298 THR A 302 VAL A 367 SITE 2 AC2 5 VAL A 477 SITE 1 AC3 4 ARG A 53 ASP A 361 ASN A 406 ASN A 479 SITE 1 AC4 10 PHE A 188 ASP A 192 VAL A 194 PHE A 195 SITE 2 AC4 10 LEU A 198 PHE A 202 PHE A 244 PHE A 296 SITE 3 AC4 10 ASP A 467 HOH A 650 SITE 1 AC5 3 ARG A 85 GLU A 424 HOH A 661 CRYST1 90.155 90.155 148.623 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011092 0.006404 0.000000 0.00000 SCALE2 0.000000 0.012808 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006728 0.00000